Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia

Completed · Phase 3 · Has a placebo group

Conditions studied: Pneumonia, Ventilator Associated Pneumonia

In brief

This study utilizes lactobacillus, or probiotics, delivered twice daily to the mouth and stomach, via feeding tube, in effort to determine whether the oral administration of a naturally occurring Lactobacillus species reduces the incidence of ventilator associated pneumonia therefore reducing intensive care unit(ICU)complications.

Key facts

Study ID
NCT00613795
Run by
Creighton University
People needed
125
Starts
2004-08-01
Expected to finish
2009-11-01
Last updated by the study team
2010-03-18

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.